| Date | Form | Description | Docs | XBRL | Pages |
| 06/13/14 | UPLOAD | SEC-generated letter |
|
2 | |
| 06/03/14 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
48 | |
| 05/30/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/08/14 | EFFECT | Notice of Effectiveness |
|
1 | |
| 05/06/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 05/06/14 | S-3/A | Registration statement for specified transactions by certain issuers |
|
29 | |
| 04/30/14 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/25/14 | EFFECT | Notice of Effectiveness |
|
1 | |
| 04/23/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 04/23/14 | S-3/A | Registration statement for specified transactions by certain issuers |
|
3 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...